A comprehensive analysis of Bordetella pertussis surface proteome and identification of new immunogenic proteins

Vaccine

Volumn 29, Issue 19, 2011, Pages 3583-3595

  Tefon, Burcu E ^a   Maaß, Sandra ^b   Özcengiz, Erkan ^c   Becher, Dörte ^b   Hecker, Michael ^b   Özcengiz, Gülay ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c Vaccine Biologicals Research Company   (Turkey)

Author keywords

Bordetella pertussis; Immunoproteomics; Surfaceome; Vaccine candidates

Indexed keywords

ABC TRANSPORTER; ADHESIN; BACTERIAL PROTEIN; BINDING PROTEIN; GENE PRODUCT; GLUTAMINE; HEAT SHOCK PROTEIN; IRON SUPEROXIDE DISMUTASE; ISOLEUCINE; LEUCINE; MEMBRANE PROTEIN; PERIPLASMIC PROTEIN; PROTEIN DNAJ; PROTEOME; VALINE;

ARTICLE; BACTERIAL STRAIN; BORDETELLA PERTUSSIS; GEL ELECTROPHORESIS; IMMUNOGENICITY; IMMUNOREACTIVITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ADHESINS, BACTERIAL; ANIMALS; ANTIGENS, BACTERIAL; BORDETELLA PERTUSSIS; FIMBRIAE PROTEINS; HSP40 HEAT-SHOCK PROTEINS; MICE; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUPEROXIDE DISMUTASE; TANDEM MASS SPECTROMETRY; VIRULENCE FACTORS, BORDETELLA;

EID: 79955032712     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.086     Document Type: Article

References (58)

1. Cherry J.D., Heininger U. Pertussis and other Bordetella infections. Textbook of pediatric infectious diseases 2004, 1588-1608. The W. B. Saunders Co, Philadelphia. 5th ed. R.D. Feigin, J.D. Cherry, G.J. Demmler, S. Kaplan (Eds.).
2. Cotter P.A., Miller J.F. Bordetella. Principles of bacterial pathogenesis 2001, 619-674. Academic Press Ltd, London. E.A. Groisman (Ed.).
3. Crowcroft N.S., Britto J. Whooping cough - a continuing problem. BMJ 2002, 324:1537-1538.
4. de Carvalho A.P., Pereira E.M. Acellular pertussis vaccine for adolescents. J Pediatr (Rio J) 2006, 82:15-24.
5. Berbers G.A., de Greeff S.C., Mooi F.R. Improving pertussis vaccination. Hum Vaccine 2009, 5:497-503.
6. Mooi F.R. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol 2010, 10:36-49.
7. Grimprel E., Baron S., Levy-Bruhl D., Garnier J.M., Njamkepo E., Guiso N., et al. Influence of vaccination coverage on pertussis transmission in France. Lancet 1999, 354:1699-1700.
8. Gilberg S., Njamkepo E., Du Châtelet I.P., Partouche H., Gueirard P., Ghasarossian C., et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage. J Infect Dis 2002, 186:415-418.
9. Koebnik R., Locher K.P., Van Gelder P. Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Mol Microbiol 2000, 37:239-253.
10. Lin J., Huang S., Zhang Q. Outer membrane proteins: key players for bacterial adaptation in host niches. Microb Infect 2002, 4:325-331.
11. Kurupati P., Teh B.K., Kumarasinghe G., Poh C.L. Identification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis. Proteomics 2006, 6:836-844.
12. Rodriguez-Ortega M.J., Norais N., Bensi G., Liberatori S., Capo S., Mora M., et al. Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol 2006, 24:191-197.
13. Pizza M., Scarlato V., Masignani V., Giuliani M.M., Arico B., Comanducci M., et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000, 287:1816-1820.
14. Maione D., Margarit I., Rinaudo C.D., Masignani V., Mora M., Scarselli M., et al. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 2005, 309:148-150.
15. Poetsch A., Wolters D. Bacterial membrane proteomics. Proteomics 2008, 8:4100-4122.
16. Wilm M., Shevchenko A., Houthaeve T., Breit S., Schweigerer L., Fotsis T., et al. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 1996, 379:466-469.
17. Gorg A., Weiss W., Dunn M.J. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4:3665-3685.
18. Ye Y., Mar E.C., Tong S., Sammons S., Fang S., Anderson L.J., et al. Application of proteomics methods for pathogen discovery. J Virol Methods 2010, 163:87-95.
19. Vidakovics M.L., Paba J., Lamberti Y., Ricart C.A., Sousa M.V., Rodriguez M.E. Profiling the Bordetella pertussis proteome during iron starvation. J Proteome Res 2007, 6:2518-2528.
20. Bottero D., Gaillard M.E., Fingermann M., Weltman G., Fernández J., Sisti F., et al. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin Vaccine Immunol 2007, 14:1490-1498.
21. Serra D.O., Lücking G., Weiland F., Schulz S., Görg A., Yantorno O.M., et al. Proteome approaches combined with Fourier transform infrared spectroscopy revealed a distinctive biofilm physiology in Bordetella pertussis. Proteomics 2008, 8:4995-5010.
22. Altindiş E., Tefon B.E., Yildirim V., Ozcengiz E., Becher D., Hecker M., et al. Immunoproteomic analysis of Bordetella pertussis and identification of new immunogenic proteins. Vaccine 2009, 27:542-548.
23. Wright A., Wait R., Begum S., Crossett B., Nagy J., Brown K. Proteomic analysis of cell surface proteins from Clostridium difficile. Proteomics 2005, 5:2443-2452.
24. Morse S.I., Bray K.K. The occurrence and properties of leukocytosis and lymphocytosis-stimulating material in the supernatant fluids of Bordetella pertussis cultures. J Exp Med 1969, 129:523-550.
25. Ramagli L.S., Rodrigez L.V. Quantitation of microgram amounts of protein in two-dimensional polyacrylamide gel electrophoresis sample buffer. Electrophoresis 1985, 6:559-563.
26. Neuhoff V., Arold N., Taube D., Ehrhardt W. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 1988, 9:255-262.
27. Eymann C., Dreisbach A., Albrecht D., Bernhardt J., Becher D., Gentner S., et al. A comprehensive proteome map of growing Bacillus subtilis cells. Proteomics 2004, 4:2849-2876.
28. Saha S., Raghava G.P. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 2006, 65:40-48.
29. Yu C.S., Chen Y.C., Lu C.H., Hwang J.K. Prediction of protein subcellular localization. Proteins 2006, 64:643-651.
30. Beissbarth T., Hyde L., Smyth G.K., Job C., Boon W.M., Tan S.S., et al. Statistical modeling of sequencing errors in SAGE libraries. Bioinformatics 2004, 20:i31-i39.
31. Old W.M., Meyer-Arendt K., Aveline-Wolf L., Pierce K.G., Mendoza A., Sevinsky J.R., et al. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics 2005, 4:1487-1502.
32. Mattoo S., Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005, 18:326-382.
33. Uhl M., Mller J. utophosphorylation and phosphotransfer in the Bordetella pertussis BvgAS signal transduction cascade. Proc Natl Acad Sci USA 1994, 91:1163-1167.
34. Steffen P., Goyard S., Ullmann A. Phosphorylated BvgA is sufficient for transcriptional activation of virulence-regulated genes in Bordetella pertussis. EMBO J 1996, 15:102-109.
35. Locht C. Molecular aspects of Bordetella pertussis pathogenesis. Int Microbiol 1999, 2:137-144.
36. Julio S.M., Cotter P.A. Characterization of the filamentous hemagglutinin-like protein FhaS in Bordetella bronchiseptica. Infect Immun 2005, 73:4960-4971.
37. Willems R., Paul A., van der Heide H.G., ter Avest A.R., Mooi F.R. Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation. EMBO J 1990, 9:2803-2809.
38. Mooi F.R., van der Heide H.G., ter Avest A.R., Welinder K.G., Livey I., van der Zeijst B.A.M., et al. Characterization of fimbrial subunits from Bordetella species. Microb Pathog 1987, 2:473-484.
39. Atakan Ablay P., Özcengiz E. Rapid purification of Bordetella pertussis fimbria 2, 3 proteins and their immunogenicities. Mikrobiyol Bul 2007, 41:11-20.
40. Brinig M.M., Cummings C.A., Sanden G.N., Stefanelli P., Lawrence A., Relman D.A. Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. J Bacteriol 2006, 188:2375-2382.
41. Yuk M.H., Harvill E.T., Miller J.F. The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. Mol Microbiol 1998, 28:945-959.
42. Abe A., Nagamatsu K., Watanabe M. The Bordetella type III secretion system: its application to vaccine development. Microbiol Immunol 2008, 52:128-133.
43. Fauconnier A., Veithen A., Gueirard P., Antoine R., Wacheul L.L., Locht C., et al. Characterization of the type III secretion locus of Bordetella pertussis. Int J Med Microbiol 2001, 290:693-705.
44. Yuk M.H., Harvill E.T., Cotter P.A., Miller J.F. Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappaB activation by the Bordetella type III secretion system. Mol Microbiol 2000, 35:991-1004.
45. Medhekar B., Shrivastava R., Mattoo S., Gingery M., Miller J.F. Bordetella Bsp22 forms a filamentous type III secretion system tip complex and is immunoprotective in vitro and in vivo. Mol Microbiol 2009, 71:492-504.
46. Nogawa H., Kuwae A., Matsuzawa T., Abe A. The type III secreted protein BopD in Bordetella bronchiseptica is complexed with BopB for pore formation on the host plasma membrane. J Bacteriol 2004, 186:3806-3813.
47. Brinig M.M., Register K.B., Ackermann M.R., Relman D.A. Genomic features of Bordetella parapertussis clades with distinct host species specificity. Genome Biol 2006, 7:R81.
48. Finn T.M., Li Z., Kocsis E. Identification of a Bordetella pertussis bvg-regulated porin-like protein. J Bacteriol 1995, 177:805-809.
49. Khelef N., DeShazer D., Friedman R.L., Guiso N. In vivo and in vitro analysis of Bordetella pertussis catalase and Fe-superoxide dismutase mutants. FEMS Microbiol Lett 1996, 142:231-235.
50. Gupta M.K., Subramanian V., Yadav J.S. Immunoproteomic identification of secretory and subcellular protein antigens and functional evaluation of the secretome fraction of Mycobacterium immunogenum, a newly recognized species of the Mycobacterium chelonae-Mycobacterium abscessus group. J Proteome Res 2009, 8:2319-2330.
51. Marin C., Hitos A.B., Rodriguez-Gonzalez I., Dollet M., Sanchez-Moreno M. Phytomonas iron superoxide dismutase: a possible molecular marker. FEMS Microbiol Lett 2004, 234:69-74.
52. Villagran M.E., Marin C., Rodriguez-Gonzalez I., De Diego J.A., Sanchez-Moreno M. Use of an iron superoxide dismutase excreted by Trypanosoma cruzi in the diagnosis of Chagas disease: seroprevalence in rural zones of the state of Queretaro, Mexico. Am J Trop Med Hyg 2005, 73:510-516.
53. Parkhill J., Sebaihia M., Preston A., Murphy L.D., Thomson N., Harris D.E., et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 2003, 35:32-40.
54. Caro V., Bouchez V., Guiso N. Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?. J Clin Microbiol 2008, 46:2125-2128.
55. Fennelly N.K., Sisti F., Higgins S.C., Ross P.J., van der Heide H., Mooi F.R., et al. Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses. Infect Immun 2008, 76:1257-1266.
56. Nesatyy V.J., Suter M.J. Proteomics for the analysis of environmental stress responses in organisms. Environ Sci Technol 2007, 41:6891-6900.
57. Khan A.S., Mujer C.V., Alefantis T.G., Connolly J.P., Mayr U.B., Walcher P., et al. Proteomics and bioinformatics strategies to design countermeasures against infectious threat agents. J Chem Inf Model 2006, 46:111-115.
58. Wu H.J., Wang A.H., Jennings M.P. Discovery of virulence factors of pathogenic bacteria. Curr Opin Chem Biol 2008, 12:93-101.